No title here
blahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblah
blahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblahblah
Med Dir Report 11-2022 here Choosing Wisely – 15 things we should question Phase 3 guidance: GDR regulations · Non-traditional meds such as antihistamines, seizure meds, other CNS meds, when…
https://drive.google.com/file/d/1ZNRuN3V22PFXiRKX6iFD2M-LnNL_Zven/view
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372215/
https://drive.google.com/file/d/1ZMCFHECiT9jy1maADv6otw-KdXej6K9N/view
Therapeutic Management of Nonhospitalized Adults With COVID-19 Nonhospitalized Adults: Therapeutic Management | COVID-19 Treatment Guidelines (nih.gov) Ritonavir-Boosted Nirmatrelvir (Paxlovid) Recommendation The Panel recommends using nirmatrelvir 300 mg with ritonavir 100…
https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html
++Nursing Home and Intermediate Care Facility Self-Assessment for COVID-19 Disease Mitigation
https://deprescribing.org/resources/deprescribing-guidelines-algorithms/
https://deprescribing.org/wp-content/uploads/2018/08/AP-deprescribing-algorithm-2018-English.pdf